MedPath

ALBUTEROL SULFATE

ALBUTEROL SULFATE Inhalation Aerosol, with Dose Indicator FOR ORAL INHALATION ONLY Prescribing Information

Approved
Approval ID

c4d6d76a-14b8-411a-8019-e2c923c2c532

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 29, 2023

Manufacturers
FDA

Cipla USA Inc.

DUNS: 078719707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

albuterol sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69097-142
Application NumberANDA209959
Product Classification
M
Marketing Category
C73584
G
Generic Name
albuterol sulfate
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateMay 29, 2023
FDA Product Classification

INGREDIENTS (4)

ALBUTEROL SULFATEActive
Quantity: 90 ug in 1 1
Code: 021SEF3731
Classification: ACTIM
OLEIC ACIDInactive
Code: 2UMI9U37CP
Classification: IACT
NORFLURANEInactive
Code: DH9E53K1Y8
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALBUTEROL SULFATE - FDA Drug Approval Details